J. B. Chemicals Pharmaceuticals CEO Whole-Time Director Nikhil Chopra Sells 63 percent Of Holding - Simply Wall St
JBCHEPHARM | 1,748 33.20 1.86% |
Under 61% of JB Chemicals' investor base is looking to short. The analysis of overall sentiment of trading JB Chemicals Pharmaceuticals stock suggests that many investors are alarmed at this time. JB Chemicals' investing sentiment shows overall attitude of investors towards JB Chemicals Pharmaceuticals.
JBCHEPHARM |
J. B. Chemicals Pharmaceuticals CEO Whole-Time Director Nikhil Chopra Sells 63 percent Of Holding Simply Wall St
Read at news.google.com
JB Chemicals Fundamental Analysis
We analyze JB Chemicals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of JB Chemicals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of JB Chemicals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Asset
Total Asset Comparative Analysis
JB Chemicals is currently under evaluation in total asset category among its peers. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
JB Chemicals Pharmac Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with JB Chemicals stock to make a market-neutral strategy. Peer analysis of JB Chemicals could also be used in its relative valuation, which is a method of valuing JB Chemicals by comparing valuation metrics with similar companies.
Peers
JB Chemicals Related Equities
VIPCLOTHNG | VIP Clothing | 2.77 | ||||
UFO | UFO Moviez | 1.98 | ||||
IXIGO | Le Travenues | 0.71 | ||||
SHYAMMETL | Shyam Metalics | 0.69 | ||||
SPAL | S P | 0.02 | ||||
HILTON | Hilton Metal | 0.71 | ||||
LLOYDSME | LLOYDS METALS | 0.76 | ||||
SYRMA | Syrma SGS | 1.43 |
Complementary Tools for JBCHEPHARM Stock analysis
When running JB Chemicals' price analysis, check to measure JB Chemicals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy JB Chemicals is operating at the current time. Most of JB Chemicals' value examination focuses on studying past and present price action to predict the probability of JB Chemicals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move JB Chemicals' price. Additionally, you may evaluate how the addition of JB Chemicals to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |